PeerView Oncology
PeerView Oncology
  • 740
  • 555 021
Focusing Decision-Making & Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at www.PeerView.com/BZV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until August 29, 2025.
Critically Focusing Decision-Making and Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC: Modeling Best Practices for Assessing Risk, Selecting Patients for Adjuvant CDK4/6i Therapy, and Fostering Treatment Adherence/Persistence
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation.
มุมมอง: 63

วีดีโอ

Navigating the Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
มุมมอง 14914 ชั่วโมงที่ผ่านมา
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TSZ865. CME/MOC/NCPD/CE/AAPA/IPCE credit will be...
Advancing Immunotherapy in Cervical Cancer Care
มุมมอง 24021 ชั่วโมงที่ผ่านมา
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC credit will be available until August 25, 2025. Ad...
Mapping a New Treatment Journey in NF1
มุมมอง 81วันที่ผ่านมา
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA credit will be available until August 21, 2025. ...
Renovating Frontline Care for Metastatic Melanoma
มุมมอง 17114 วันที่ผ่านมา
Hussein Tawbi, MD, PhD - Renovating Frontline Care for Metastatic Melanoma: Guidance on Upgrading to Combination Immunotherapy Standards Across Disease Presentations This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids,...
Optimal SCLC Care With Established and Innovative Therapies
มุมมอง 324หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HXN865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options
มุมมอง 239หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VXT865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Clotting the Gaps in VWD Care
มุมมอง 138หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/IPCE information, and to apply for credit, please visit us at PeerView.com/GXU865. CME/MOC/NCPD/IPCE credit will be available until...
Transforming MCL Management Guidance on Selecting and Using BTKi Platforms as First Line Therapy
มุมมอง 148หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/QHV865. CME/MOC credit will be available until July 17, 2025. Step...
Innovation in CLL The Practicalities and Potential of Finite Therapy With BTKi Platforms
มุมมอง 150หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/UFU865. CME/MOC credit will be available until July 15, 2025. Open...
Candid Conversations on Modern Urothelial Cancer Management
มุมมอง 2642 หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GJT865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Unleashing the Innovation Era in AML
มุมมอง 1902 หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be avail...
Advances in Endometrial Carcinoma Treatment: The Power of Immunotherapy and Other Emerging Regimens
มุมมอง 4592 หลายเดือนก่อน
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025. Na...
Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early Stage NSCLC
มุมมอง 2692 หลายเดือนก่อน
Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early Stage NSCLC
Three Rs for Modern Myeloma Care
มุมมอง 1102 หลายเดือนก่อน
Three Rs for Modern Myeloma Care
On Target: Using Trop-2-Directed Therapeutics for Urothelial Carcinoma
มุมมอง 1782 หลายเดือนก่อน
On Target: Using Trop-2-Directed Therapeutics for Urothelial Carcinoma
Expanding Frontline Frontiers in Multiple Myeloma Care
มุมมอง 992 หลายเดือนก่อน
Expanding Frontline Frontiers in Multiple Myeloma Care
Decoding Biomarker Testing and Targeted Therapy in NSCLC
มุมมอง 4282 หลายเดือนก่อน
Decoding Biomarker Testing and Targeted Therapy in NSCLC
CONTROL Myelofibrosis
มุมมอง 2342 หลายเดือนก่อน
CONTROL Myelofibrosis
Maximizing the Role of ADCs in Urothelial Carcinoma
มุมมอง 1362 หลายเดือนก่อน
Maximizing the Role of ADCs in Urothelial Carcinoma
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
มุมมอง 7812 หลายเดือนก่อน
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC
มุมมอง 3312 หลายเดือนก่อน
Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC
Catalysts for Change in Gastric & GEJ Cancer
มุมมอง 3582 หลายเดือนก่อน
Catalysts for Change in Gastric & GEJ Cancer
HR+, HER2 , High Risk EBC A Practical Roadmap for CDK4 6 Inhibition in the Adjuvant Setting
มุมมอง 3832 หลายเดือนก่อน
HR , HER2 , High Risk EBC A Practical Roadmap for CDK4 6 Inhibition in the Adjuvant Setting
Overcoming BTK Resistance With Non-Covalent BTKi
มุมมอง 1552 หลายเดือนก่อน
Overcoming BTK Resistance With Non-Covalent BTKi
The Collaborative Benchmark for HCC: Critical Discussions Between IR-Oncology Professionals
มุมมอง 3853 หลายเดือนก่อน
The Collaborative Benchmark for HCC: Critical Discussions Between IR-Oncology Professionals
Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
มุมมอง 963 หลายเดือนก่อน
Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
มุมมอง 4633 หลายเดือนก่อน
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
มุมมอง 1083 หลายเดือนก่อน
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
Modern Team-Based Therapeutic Management for Bladder Cancer Care
มุมมอง 1683 หลายเดือนก่อน
Modern Team-Based Therapeutic Management for Bladder Cancer Care